(ARAV) - Management Comments

(ARAV) – Management Comments

Mar 22, 2022 07:02 AM Aravive Inc. (ARAV) Appoints Scott Dove, Ph.D., as COO
Apr 27, 2021 07:37 AM Aravive Inc. (ARAV) Reports First Patient Dosed in Phase 3 Registrational Trial Evaluating AVB-500 in Patients with Platinum Resistant Ovarian Cancer
Nov 19, 2020 07:20 AM
Sep 17, 2020 07:06 AM
Jul 23, 2020 07:16 AM
Jan 13, 2020 08:10 AM
Jan 9, 2020 04:21 PM
Dec 20, 2019 08:03 AM
Sep 27, 2019 10:16 AM
Aug 8, 2019 05:29 PM
Jul 31, 2019 07:24 AM
Jul 8, 2019 07:08 AM
Mar 19, 2019 07:27 AM
Dec 11, 2018 08:07 AM
Nov 13, 2018 07:10 AM